Literature DB >> 25036773

Tracking hippo in the cancer jungle.

Jung H Suh1, Julie D Saba2.   

Abstract

Signaling through the Hippo pathway controls major aspects of cell growth and proliferation. Focusing on the metabolic consequences of Hippo signaling, Mulvihill and colleagues in this issue of Chemistry & Biology employ a large scale, integrative approach and uncover downstream reorganization of cellular metabolism when the effector TAZ is upregulated, identifying new connections to lipid metabolism.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25036773      PMCID: PMC5982109          DOI: 10.1016/j.chembiol.2014.07.002

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  9 in total

1.  The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells.

Authors:  Michelangelo Cordenonsi; Francesca Zanconato; Luca Azzolin; Mattia Forcato; Antonio Rosato; Chiara Frasson; Masafumi Inui; Marco Montagner; Anna R Parenti; Alessandro Poletti; Maria Grazia Daidone; Sirio Dupont; Giuseppe Basso; Silvio Bicciato; Stefano Piccolo
Journal:  Cell       Date:  2011-11-11       Impact factor: 41.582

2.  Metabolic control of YAP and TAZ by the mevalonate pathway.

Authors:  Giovanni Sorrentino; Naomi Ruggeri; Valeria Specchia; Michelangelo Cordenonsi; Miguel Mano; Sirio Dupont; Andrea Manfrin; Eleonora Ingallina; Roberta Sommaggio; Silvano Piazza; Antonio Rosato; Stefano Piccolo; Giannino Del Sal
Journal:  Nat Cell Biol       Date:  2014-03-23       Impact factor: 28.824

3.  Metabolic profiling reveals PAFAH1B3 as a critical driver of breast cancer pathogenicity.

Authors:  Melinda M Mulvihill; Daniel I Benjamin; Xiaodan Ji; Erwan Le Scolan; Sharon M Louie; Alice Shieh; McKenna Green; Tara Narasimhalu; Patrick J Morris; Kunxin Luo; Daniel K Nomura
Journal:  Chem Biol       Date:  2014-06-19

Review 4.  Cancer treatment strategies targeting sphingolipid metabolism.

Authors:  Babak Oskouian; Julie D Saba
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

5.  Hippo pathway activity influences liver cell fate.

Authors:  Dean Yimlamai; Constantina Christodoulou; Giorgio G Galli; Kilangsungla Yanger; Brian Pepe-Mooney; Basanta Gurung; Kriti Shrestha; Patrick Cahan; Ben Z Stanger; Fernando D Camargo
Journal:  Cell       Date:  2014-06-05       Impact factor: 41.582

Review 6.  Statins: perspectives in cancer therapeutics.

Authors:  Laurent Corcos; Catherine Le Jossic-Corcos
Journal:  Dig Liver Dis       Date:  2013-03-13       Impact factor: 4.088

7.  Aspirin hydrolysis in plasma is a variable function of butyrylcholinesterase and platelet-activating factor acetylhydrolase 1b2 (PAFAH1b2).

Authors:  Gang Zhou; Gopal K Marathe; Jaana Hartiala; Stanley L Hazen; Hooman Allayee; W H Wilson Tang; Thomas M McIntyre
Journal:  J Biol Chem       Date:  2013-03-18       Impact factor: 5.157

Review 8.  The Hippo pathway and human cancer.

Authors:  Kieran F Harvey; Xiaomeng Zhang; David M Thomas
Journal:  Nat Rev Cancer       Date:  2013-03-07       Impact factor: 60.716

Review 9.  Understanding the Warburg effect: the metabolic requirements of cell proliferation.

Authors:  Matthew G Vander Heiden; Lewis C Cantley; Craig B Thompson
Journal:  Science       Date:  2009-05-22       Impact factor: 47.728

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.